english.prescrire.org > Spotlight > Archives : 2025 > The Prescrire Drug Awards for 2024

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

The Prescrire Drug Awards for 2024

Le Palmarès des Médicaments Prescrire awarded one Pilule d'Or (Golden Pill) this year, to a drug for a neglected disease. One other drug was deemed "Noteworthy". Although some of the other drugs analysed in Prescrire over the course of 2024 represented a therapeutic advance for certain patients, especially in the field of oncology, we chose not to give them an award because their clinical evaluation was insufficiently robust (see "Why drugs should be evaluated in several randomised comparative trials" Prescrire Int May 2025, FREE).
Full article available for download (FREE)

Every month, Prescrire's Editorial Staff help health professionals decide which of the multitude of newly authorised products or indications are worth adding to their list of useful treatment options, and which are to be avoided. We do this by conducting systematic analyses of the relevant evaluation data available on new drugs, new indications, new pharmaceutical forms and new dose strengths authorised in Europe or in France.

Fexinidazole Winthrop° was awarded the 2024 Pilule d'Or in recognition of the major therapeutic advance it represents in the treatment of a neglected disease.

Bicafres°, sodium bicarbonate gastro-resistant tablets, has been granted marketing authorisation in France, where, previously, oral sodium bicarbonate was only available as an extemporaneous preparation. It earned the title of "Noteworthy" drug in recognition of this marketing authorisation procedure, which guarantees the quality of a cheap and useful drug.

 

 

©Prescrire 1 May 2025

Source: "The Prescrire Awards for 2024" Prescrire Int 2025; 34 (270): 136-139. FREE.

Enjoy full access to Prescrire International, and support independent information

 

Share
Share on  Facebook  
 
 
See also:

"Why drugs should be
evaluated in several
randomised comparative
trials"
Prescrire Int 2025;
34 (270): 115.
FREE
 
"Negligence"
Prescrire Int 2023;
32 (246): 59.
FREE
 
"Fexinidazole
(Fexinidazole Winthrop°)
in sleeping sickness
caused by Trypanosoma
brucei rhodesiense"
Prescrire Int 2025;
34 (269): 94-95.
Subscribers only